의료 정보 시스템 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 도입 형태별, 컴포넌트별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Healthcare Information System Market Summary

The global healthcare information system market size was estimated at USD 773.99 billion in 2025 and is projected to reach USD 2,660.15 billion, growing at a CAGR of 16.9% from 2026 to 2033. Implementing Healthcare Information Systems (HIS), such as population health management significantly advances disease prevention and management, resulting in substantial financial savings.

Moreover, growing demand for remote patient monitoring for improved out-of-hospital care is a primary factor driving the market's growth.Furthermore, increasing usage of smartphones, technologically advanced infrastructure, and an increase in strategic initiatives and investments supporting eHealth and digital health are driving the market's growth over the forecast period.

Global Healthcare Information System Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare information system market report based on application, deployment mode, component, healthcare providers, end use, and region.

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Hospital Information System
  • By Healthcare Providers
  • Public
  • Private
  • By Type
  • Clinical Information System (CIS)
  • Electronic Health Records (EHR)
  • Electronic Medical Records (EMR)
  • Clinical Decision Support Systems (CDSS)
  • Nursing Information Systems
  • Computerized Physician Order Entry (CPOE)
  • Real-Time Healthcare Monitoring Software
  • Patient Administration System
  • Admission/Discharge/Transfer System
  • Scheduling & Registration Systems
  • Hospital Workflow Management
  • By End Use
  • Hospitals
  • Ambulatory Care Centers
  • Pharmacy
  • Diagnostic & Imaging Centers
  • Academic and Research Institutes
  • Other End Use
• Diagnostic Imaging IT (DIIT)
  • By Healthcare Providers
  • Public
  • Private
  • By Type
  • Radiology Information Systems (RIS)
  • Monitoring Analysis Software
  • Picture Archiving and Communication Systems
  • Vendor Neutral Archives (VNA)
  • Advanced Visualization Software
  • AI/ML-based Tools for Image Analysis
  • By End Use
  • Hospitals
  • Ambulatory Care Centers
  • Pharmacy
  • Diagnostic & Imaging Centers
  • Academic and Research Institutes
  • Other End Use
• IVD Informatics (Digital & Software Layer Only)
  • By Healthcare Providers
  • Public
  • Private
  • By Type
  • Laboratory Information Management Systems (LIMS)
  • Middleware Solutions
  • Quality Control Software
  • Diagnostic Data Management
  • By End Use
  • Hospitals
  • Ambulatory Care Centers
  • Pharmacy
  • Diagnostic & Imaging Centers
  • Academic and Research Institutes
  • Other End Use
• Social & Connected Care (S&CC)
  • By Healthcare Providers
  • Public
  • Private
  • By Type
  • Telehealth
  • Remote Patient Monitoring System
  • Population Health Management
  • Patient Engagement Software
  • Care Coordination Software
  • By End Use
  • Hospitals
  • Ambulatory Care Centers
  • Pharmacy
  • Diagnostic & Imaging Centers
  • Academic and Research Institutes
  • Other End Use
• Revenue Cycle Management
  • By Healthcare Providers
  • Public
  • Private
  • By End Use
  • Hospitals
  • Ambulatory Care Centers
  • Pharmacy
  • Diagnostic & Imaging Centers
  • Academic and Research Institutes
  • Other End Use
• Pharmacy Automation Systems
  • By Healthcare Providers
  • Public
  • Private
  • By Type
  • Medication Dispensing Systems
  • Packaging and labeling systems
  • Storage and Retrieval Systems
  • Automated Medication Compounding Systems
  • Tabletop Tablet Counters
  • By End Use
  • Hospitals
  • Pharmacy
  • Diagnostic & Imaging Centers
  • Academic and Research Institutes
  • Other End Use
• Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
• Web-based
• On-premises
• Cloud-based
• Component Outlook (Revenue, USD Million, 2021 - 2033)
• Hardware
• Software & Systems
• Services
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Care Centers
• Pharmacy
• Diagnostic & Imaging Centers
• Academic and Research Institutes
• Other End Use
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Belgium
  • Norway
  • Denmark
  • Sweden
  • Ireland
  • Austria
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
  • Singapore
  • Malaysia
  • Indonesia
  • Philippines
  • New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Morocco
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Model Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
• 3.4. Case Study Insights

Chapter 4. Application Business Analysis

• 4.1. Application Market Share, 2025 & 2033
• 4.2. Application Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 4.4. Hospital Information System
  • 4.4.1. Hospital information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. By Healthcare Providers
    • 4.4.2.1. Public
      • 4.4.2.1.1.Public market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2.2. Private
      • 4.4.2.2.1.Private market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. By Type
    • 4.4.3.1. Clinical Information System (CIS)
      • 4.4.3.1.1.Clinical information systems market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.2.Electronic Health Record
        • 4.4.3.1.2.1. Electronic health record market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.3.Electronic Medical Record
        • 4.4.3.1.3.1. Electronic medical record market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.4.Clinical Decision Support Systems (CDSS)
        • 4.4.3.1.4.1. Clinical Decision Support Systems (CDSS) market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.5.Nursing Information Systems
        • 4.4.3.1.5.1. Nursing information systems market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.6.Computerized Physician Order Entry (CPOE)
        • 4.4.3.1.6.1. Computerized physician order entry (CPOE) market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.1.7.Real-Time Healthcare Monitoring Software
        • 4.4.3.1.7.1. Real-time healthcare monitoring software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3.2. Patient Administration System
      • 4.4.3.2.1.Patient administration system market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2.2.Scheduling & Registration Systems
        • 4.4.3.2.2.1. Scheduling & registration systems market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2.3.Admission/Discharge/Transfer System
        • 4.4.3.2.3.1. Admission/discharge/transfer system market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2.4.Storage & Retrieval System
        • 4.4.3.2.4.1. Storage & retrieval system estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2.5.Hospital Workflow Management
        • 4.4.3.2.5.1. Hospital workflow management market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. By End Use
    • 4.4.4.1. Hospitals
      • 4.4.4.1.1.Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.2. Ambulatory Care Centers
      • 4.4.4.2.1.Ambulatory care centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.3. Pharmacy
      • 4.4.4.3.1.Pharmacy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.4. Diagnostic & Imaging Centers
      • 4.4.4.4.1.Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.5. Academic and Research Institutes
      • 4.4.4.5.1.Academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4.6. Other End Use
      • 4.4.4.6.1.Other end use market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Diagnostic Imaging IT (DIIT)
  • 4.5.1. Diagnostic Imaging IT (DIIT) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. By Healthcare Providers
    • 4.5.2.1. Public
      • 4.5.2.1.1.Public market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2.2. Private
      • 4.5.2.2.1.Private market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. By Type
    • 4.5.3.1. Radiology Information Systems (RIS)
      • 4.5.3.1.1.Radiology information systems (RIS) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.2. Monitoring Analysis Software
      • 4.5.3.2.1.Monitoring analysis software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.3. Picture Archiving and Communication Systems
      • 4.5.3.3.1.Picture archiving and communication systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.4. Vendor Neutral Archives (VNA)
      • 4.5.3.4.1.Vendor neutral archives (VNA) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.5. Advanced Visualization Software
      • 4.5.3.5.1.Advanced visualization software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3.6. AI/ML-based Tools for Image Analysis
      • 4.5.3.6.1.AI/ML-based tools for image analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.4. By End Use
    • 4.5.4.1. Hospitals
      • 4.5.4.1.1.Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4.2. Ambulatory Care Centers
      • 4.5.4.2.1.Ambulatory care centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4.3. Pharmacy
      • 4.5.4.3.1.Pharmacy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4.4. Diagnostic & Imaging Centers
      • 4.5.4.4.1.Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4.5. Academic and Research Institutes
      • 4.5.4.5.1.Academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4.6. Other End Use
      • 4.5.4.6.1.Other end use market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.6. IVD Informatics (Digital & Software Layer Only)
  • 4.6.1. IVD informatics (digital & software layer only) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.2. By Healthcare Providers
    • 4.6.2.1. Public
      • 4.6.2.1.1.Public market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2.2. Private
      • 4.6.2.2.1.Private market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.3. By Type
    • 4.6.3.1. Laboratory Information Management Systems (LIMS)
      • 4.6.3.1.1.Laboratory Information Management Systems (LIMS) market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3.2. Middleware Solutions
      • 4.6.3.2.1.Middleware solutions market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3.3. Quality Control Software
      • 4.6.3.3.1.Quality control software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3.4. Diagnostic Data Management
      • 4.6.3.4.1.Diagnostic data management market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6.4. By End Use
    • 4.6.4.1. Hospitals
      • 4.6.4.1.1.Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4.2. Ambulatory Care Centers
      • 4.6.4.2.1.Ambulatory care centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4.3. Pharmacy
      • 4.6.4.3.1.Pharmacy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4.4. Diagnostic & Imaging Centers
      • 4.6.4.4.1.Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4.5. Academic and Research Institutes
      • 4.6.4.5.1.Academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4.6. Other End Use
      • 4.6.4.6.1.Other end use market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.7. Social & Connected Care (S&CC)
  • 4.7.1. Social & Connected Care (S&CC) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.2. By Healthcare Providers
    • 4.7.2.1. Public
      • 4.7.2.1.1.Public market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2.2. Private
      • 4.7.2.2.1.Private market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.3. By Type
    • 4.7.3.1. Telehealth
      • 4.7.3.1.1.Telehealth market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3.2. Remote Patient Monitoring System
      • 4.7.3.2.1.Remote patient monitoring system market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3.3. Population Health Management
      • 4.7.3.3.1.Population health management market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3.4. Patient Engagement Software
      • 4.7.3.4.1.Patient engagement software market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3.5. Care Coordination Software
      • 4.7.3.5.1.Care coordination software market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7.4. By End Use
    • 4.7.4.1. Hospitals
      • 4.7.4.1.1.Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4.2. Ambulatory Care Centers
      • 4.7.4.2.1.Ambulatory care centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4.3. Pharmacy
      • 4.7.4.3.1.Pharmacy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4.4. Diagnostic & Imaging Centers
      • 4.7.4.4.1.Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4.5. Academic and Research Institutes
      • 4.7.4.5.1.Academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.4.6. Other End Use
      • 4.7.4.6.1.Other end use market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.8. Revenue Cycle Management
  • 4.8.1. Revenue cycle management market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8.2. By Healthcare Providers
    • 4.8.2.1. Public
      • 4.8.2.1.1.Public market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.2.2. Private
      • 4.8.2.2.1.Private market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8.3. By End Use
    • 4.8.3.1. Hospitals
      • 4.8.3.1.1.Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3.2. Ambulatory Care Centers
      • 4.8.3.2.1.Ambulatory care centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3.3. Pharmacy
      • 4.8.3.3.1.Pharmacy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3.4. Diagnostic & Imaging Centers
      • 4.8.3.4.1.Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3.5. Academic and Research Institutes
      • 4.8.3.5.1.Academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3.6. Other End Use
      • 4.8.3.6.1.Other end use market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.9. Pharmacy Automation Systems
  • 4.9.1. Pharmacy automation systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9.2. By Healthcare Providers
    • 4.9.2.1. Public
      • 4.9.2.1.1.Public market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.2.2. Private
      • 4.9.2.2.1.Private market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9.3. By Type
    • 4.9.3.1. Medication Dispensing Systems
      • 4.9.3.1.1.Medication dispensing systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.3.2. Packaging and labeling systems
      • 4.9.3.2.1.Packaging and labeling systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.3.3. Storage and Retrieval Systems
      • 4.9.3.3.1.Storage and retrieval systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.3.4. Automated Medication Compounding Systems
      • 4.9.3.4.1.Automated medication compounding systems market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.3.5. Tabletop Tablet Counters
      • 4.9.3.5.1.Tabletop tablet counters market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9.4. By End Use
    • 4.9.4.1. Hospitals
      • 4.9.4.1.1.Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.4.2. Pharmacy
      • 4.9.4.2.1.Pharmacy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.4.3. Diagnostic & Imaging Centers
      • 4.9.4.3.1.Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.4.4. Academic and Research Institutes
      • 4.9.4.4.1.Academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.9.4.5. Other End Use
      • 4.9.4.5.1.Other end use market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Deployment Business Analysis

• 5.1. Deployment Market Share, 2025 & 2033
• 5.2. Deployment Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analyses, by Deployment, 2021 to 2033 (USD Million)
• 5.4. Web-based
  • 5.4.1. Web-based market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. On-premises
  • 5.5.1. On-premises market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Cloud-based
  • 5.6.1. Cloud-based market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Component Business Analysis

• 6.1. Component Market Share, 2025 & 2033
• 6.2. Component Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analyses, by Component, 2021 to 2033 (USD Million)
• 6.4. Hardware
  • 6.4.1. Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Software & Systems
  • 6.5.1. Software & systems market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Services
  • 6.6.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. End use Business Analysis

• 7.1. End use Market Share, 2025 & 2033
• 7.2. End use Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analyses, by End use, 2021 to 2033 (USD Million)
• 7.4. Hospitals & Ambulatory Services
  • 7.4.1. Hospitals & Ambulatory Services market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Ambulatory Care Centers
  • 7.5.1. Ambulatory Care Centers market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Pharmacy
  • 7.6.1. Pharmacy market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Diagnostic & Imaging Centers
  • 7.7.1. Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.8. Academic and Research Institutes
  • 7.8.1. Academic and research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.9. Other End Use
  • 7.9.1. Others end use market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2025 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 8.4. North America
  • 8.4.1. North America healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key country dynamic
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive insights
    • 8.4.2.4. U.S. healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key country dynamic
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive insights
    • 8.4.3.4. Canada healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key country dynamic
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive insights
    • 8.4.4.4. Mexico healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key country dynamic
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive insights
    • 8.5.2.4. UK healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key country dynamic
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive insights
    • 8.5.3.4. Germany healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key country dynamic
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive insights
    • 8.5.4.4. France healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key country dynamic
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive insights
    • 8.5.5.4. Italy healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key country dynamic
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive insights
    • 8.5.6.4. Spain healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Norway
    • 8.5.7.1. Key country dynamic
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive insights
    • 8.5.7.4. Norway healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key country dynamic
    • 8.5.8.2. Regulatory framework
    • 8.5.8.3. Competitive insights
    • 8.5.8.4. Sweden healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.9. Denmark
    • 8.5.9.1. Key country dynamic
    • 8.5.9.2. Regulatory framework
    • 8.5.9.3. Competitive insights
    • 8.5.9.4. Denmark healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.10. Russia
    • 8.5.10.1. Key country dynamic
    • 8.5.10.2. Regulatory framework
    • 8.5.10.3. Competitive insights
    • 8.5.10.4. Russia healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.11. Netherlands
    • 8.5.11.1. Key country dynamic
    • 8.5.11.2. Regulatory framework
    • 8.5.11.3. Competitive insights
    • 8.5.11.4. Netherlands healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.12. Switzerland
    • 8.5.12.1. Key country dynamic
    • 8.5.12.2. Regulatory framework
    • 8.5.12.3. Competitive insights
    • 8.5.12.4. Switzerland healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.13. Belgium
    • 8.5.13.1. Key country dynamic
    • 8.5.13.2. Regulatory framework
    • 8.5.13.3. Competitive insights
    • 8.5.13.4. Belgium healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.14. Ireland
    • 8.5.14.1. Key country dynamic
    • 8.5.14.2. Regulatory framework
    • 8.5.14.3. Competitive insights
    • 8.5.14.4. Ireland healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.15. Austria
    • 8.5.15.1. Key country dynamic
    • 8.5.15.2. Regulatory framework
    • 8.5.15.3. Competitive insights
    • 8.5.15.4. Austria healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key country dynamic
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive insights
    • 8.6.2.4. Japan healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key country dynamic
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive insights
    • 8.6.3.4. China healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key country dynamic
    • 8.6.4.2. Regulatory framework
    • 8.6.4.3. Competitive insights
    • 8.6.4.4. India healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key country dynamic
    • 8.6.5.2. Regulatory framework
    • 8.6.5.3. Competitive insights
    • 8.6.5.4. Australia healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key country dynamic
    • 8.6.6.2. Regulatory framework
    • 8.6.6.3. Competitive insights
    • 8.6.6.4. South Korea healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key country dynamic
    • 8.6.7.2. Regulatory framework
    • 8.6.7.3. Competitive insights
    • 8.6.7.4. Thailand healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.8. Singapore
    • 8.6.8.1. Key country dynamic
    • 8.6.8.2. Regulatory framework
    • 8.6.8.3. Competitive insights
    • 8.6.8.4. Singapore healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.9. Malaysia
    • 8.6.9.1. Key country dynamic
    • 8.6.9.2. Regulatory framework
    • 8.6.9.3. Competitive insights
    • 8.6.9.4. Malaysia healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.10. Indonesia
    • 8.6.10.1. Key country dynamic
    • 8.6.10.2. Regulatory framework
    • 8.6.10.3. Competitive insights
    • 8.6.10.4. Indonesia healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.11. Philippines
    • 8.6.11.1. Key country dynamic
    • 8.6.11.2. Regulatory framework
    • 8.6.11.3. Competitive insights
    • 8.6.11.4. Philippines healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.12. New Zealand
    • 8.6.12.1. Key country dynamic
    • 8.6.12.2. Regulatory framework
    • 8.6.12.3. Competitive insights
    • 8.6.12.4. New Zealand healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key country dynamic
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive insights
    • 8.7.2.4. Brazil healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key country dynamic
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive insights
    • 8.7.3.4. Argentina healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key country dynamic
    • 8.8.2.2. Regulatory framework
    • 8.8.2.3. Competitive insights
    • 8.8.2.4. South Africa healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key country dynamic
    • 8.8.3.2. Regulatory framework
    • 8.8.3.3. Competitive insights
    • 8.8.3.4. Saudi Arabia healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key country dynamic
    • 8.8.4.2. Regulatory framework
    • 8.8.4.3. Competitive insights
    • 8.8.4.4. UAE healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key country dynamic
    • 8.8.5.2. Regulatory framework
    • 8.8.5.3. Competitive insights
    • 8.8.5.4. Kuwait healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8.6. Morocco
    • 8.8.6.1. Key country dynamic
    • 8.8.6.2. Regulatory framework
    • 8.8.6.3. Competitive insights
    • 8.8.6.4. Morocco healthcare information system market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Overview
• 9.2. Company Market Position Analysis
• 9.3. Company Categorization
• 9.4. Strategy Mapping
• 9.5. Company Profiles/Listing
  • 9.5.1. Athenahealth, Inc.
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. Oracle (Cerner)
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. GE Healthcare
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Veradigm LLC (formerly known as Allscripts)
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. Epic Systems Corporation
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. eClinicalWorks
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. Greenway Health, LLC
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. NextGen Healthcare, Inc. (acquired by Thoma Bravo)
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. Medical Information Technology, Inc. (Meditech)
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product benchmarking
    • 9.5.9.4. Strategic initiatives
  • 9.5.10. TruBridge (CPSI)
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product benchmarking
    • 9.5.10.4. Strategic initiatives
  • 9.5.11. AdvancedMD, Inc.
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product benchmarking
    • 9.5.11.4. Strategic initiatives
  • 9.5.12. CureMD Healthcare
    • 9.5.12.1. Overview
    • 9.5.12.2. Financial performance
    • 9.5.12.3. Product benchmarking
    • 9.5.12.4. Strategic initiatives
  • 9.5.13. McKesson Corporation
    • 9.5.13.1. Overview
    • 9.5.13.2. Financial performance
    • 9.5.13.3. Product benchmarking
    • 9.5.13.4. Strategic initiatives
  • 9.5.14. IQVIA
    • 9.5.14.1. Overview
    • 9.5.14.2. Financial performance
    • 9.5.14.3. Product benchmarking
    • 9.5.14.4. Strategic initiatives
  • 9.5.15. Optum, Inc. (subsidiary of UnitedHealth Group)
    • 9.5.15.1. Overview
    • 9.5.15.2. Financial performance
    • 9.5.15.3. Product benchmarking
    • 9.5.15.4. Strategic initiatives
  • 9.5.16. Medecision
    • 9.5.16.1. Overview
    • 9.5.16.2. Financial performance
    • 9.5.16.3. Product benchmarking
    • 9.5.16.4. Strategic initiatives
  • 9.5.17. Cegedim Healthcare Solutions
    • 9.5.17.1. Overview
    • 9.5.17.2. Financial performance
    • 9.5.17.3. Product benchmarking
    • 9.5.17.4. Strategic initiatives
  • 9.5.18. Agfa-Gevaert Group.
    • 9.5.18.1. Overview
    • 9.5.18.2. Financial performance
    • 9.5.18.3. Product benchmarking
    • 9.5.18.4. Strategic initiatives
  • 9.5.19. Hewlett Packard Enterprise Development LP
    • 9.5.19.1. Overview
    • 9.5.19.2. Financial performance
    • 9.5.19.3. Product benchmarking
    • 9.5.19.4. Strategic initiatives
  • 9.5.20. Carestream Health.
    • 9.5.20.1. Overview
    • 9.5.20.2. Financial performance
    • 9.5.20.3. Product benchmarking
    • 9.5.20.4. Strategic initiatives
  • 9.5.21. Novarad Corporation
    • 9.5.21.1. Overview
    • 9.5.21.2. Financial performance
    • 9.5.21.3. Product benchmarking
    • 9.5.21.4. Strategic initiatives
  • 9.5.22. CompuGroup Medical
    • 9.5.22.1. Overview
    • 9.5.22.2. Financial performance
    • 9.5.22.3. Product benchmarking
    • 9.5.22.4. Strategic initiatives
  • 9.5.23. Ada Health GmbH
    • 9.5.23.1. Overview
    • 9.5.23.2. Financial performance
    • 9.5.23.3. Product benchmarking
    • 9.5.23.4. Strategic initiatives
  • 9.5.24. SWORD Health
    • 9.5.24.1. Overview
    • 9.5.24.2. Financial performance
    • 9.5.24.3. Product benchmarking
    • 9.5.24.4. Strategic initiatives
  • 9.5.25. Infor.
    • 9.5.25.1. Overview
    • 9.5.25.2. Financial performance
    • 9.5.25.3. Product benchmarking
    • 9.5.25.4. Strategic initiatives
  • 9.5.26. EnlivenHealth (Omnicell)
    • 9.5.26.1. Overview
    • 9.5.26.2. Financial performance
    • 9.5.26.3. Product benchmarking
    • 9.5.26.4. Strategic initiatives
  • 9.5.27. Experian Information Solutions, Inc
    • 9.5.27.1. Overview
    • 9.5.27.2. Financial performance
    • 9.5.27.3. Product benchmarking
    • 9.5.27.4. Strategic initiatives
  • 9.5.28. Belong.Life
    • 9.5.28.1. Overview
    • 9.5.28.2. Financial performance
    • 9.5.28.3. Product benchmarking
    • 9.5.28.4. Strategic initiatives
  • 9.5.29. PatientBond (acquired by Upfront in August 2022)
    • 9.5.29.1. Overview
    • 9.5.29.2. Financial performance
    • 9.5.29.3. Product benchmarking
    • 9.5.29.4. Strategic initiatives
  • 9.5.30. Inovalon
    • 9.5.30.1. Overview
    • 9.5.30.2. Financial performance
    • 9.5.30.3. Product benchmarking
    • 9.5.30.4. Strategic initiatives
  • 9.5.31. Digital Pharmacist
    • 9.5.31.1. Overview
    • 9.5.31.2. Financial performance
    • 9.5.31.3. Product benchmarking
    • 9.5.31.4. Strategic initiatives
  • 9.5.32. Keycentrix, LLC
    • 9.5.32.1. Overview
    • 9.5.32.2. Financial performance
    • 9.5.32.3. Product benchmarking
    • 9.5.32.4. Strategic initiatives
  • 9.5.33. Cassian Solutions (CassianRx)
    • 9.5.33.1. Overview
    • 9.5.33.2. Financial performance
    • 9.5.33.3. Product benchmarking
    • 9.5.33.4. Strategic initiatives
  • 9.5.34. Equipo Health Inc.
    • 9.5.34.1. Overview
    • 9.5.34.2. Financial performance
    • 9.5.34.3. Product benchmarking
    • 9.5.34.4. Strategic initiatives
  • 9.5.35. WellSky
    • 9.5.35.1. Overview
    • 9.5.35.2. Financial performance
    • 9.5.35.3. Product benchmarking
    • 9.5.35.4. Strategic initiatives
  • 9.5.36. ResMed
    • 9.5.36.1. Overview
    • 9.5.36.2. Financial performance
    • 9.5.36.3. Product benchmarking
    • 9.5.36.4. Strategic initiatives
  • 9.5.37. Koninklijke Philips N.V.
    • 9.5.37.1. Overview
    • 9.5.37.2. Financial performance
    • 9.5.37.3. Product benchmarking
    • 9.5.37.4. Strategic initiatives
  • 9.5.38. Klara Technologies, Inc.
    • 9.5.38.1. Overview
    • 9.5.38.2. Financial performance
    • 9.5.38.3. Product benchmarking
    • 9.5.38.4. Strategic initiatives
  • 9.5.39. Solutionreach, Inc.
    • 9.5.39.1. Overview
    • 9.5.39.2. Financial performance
    • 9.5.39.3. Product benchmarking
    • 9.5.39.4. Strategic initiatives
  • 9.5.40. MEDHOST
    • 9.5.40.1. Overview
    • 9.5.40.2. Financial performance
    • 9.5.40.3. Product benchmarking
    • 9.5.40.4. Strategic initiatives
  • 9.5.41. Health Catalyst
    • 9.5.41.1. Overview
    • 9.5.41.2. Financial performance
    • 9.5.41.3. Product benchmarking
    • 9.5.41.4. Strategic initiatives
  • 9.5.42. AiCure
    • 9.5.42.1. Overview
    • 9.5.42.2. Financial performance
    • 9.5.42.3. Product benchmarking
    • 9.5.42.4. Strategic initiatives
  • 9.5.43. Medadvisor Solutions
    • 9.5.43.1. Overview
    • 9.5.43.2. Financial performance
    • 9.5.43.3. Product benchmarking
    • 9.5.43.4. Strategic initiatives
  • 9.5.44. Innovaccer, Inc.
    • 9.5.44.1. Overview
    • 9.5.44.2. Financial performance
    • 9.5.44.3. Product benchmarking
    • 9.5.44.4. Strategic initiatives
  • 9.5.45. EmpiRx Health, LLC.
    • 9.5.45.1. Overview
    • 9.5.45.2. Financial performance
    • 9.5.45.3. Product benchmarking
    • 9.5.45.4. Strategic initiatives
  • 9.5.46. IBM
    • 9.5.46.1. Overview
    • 9.5.46.2. Financial performance
    • 9.5.46.3. Product benchmarking
    • 9.5.46.4. Strategic initiatives
  • 9.5.47. Huma
    • 9.5.47.1. Overview
    • 9.5.47.2. Financial performance
    • 9.5.47.3. Product benchmarking
    • 9.5.47.4. Strategic initiatives
  • 9.5.48. AllazoHealth (AssistRx)
    • 9.5.48.1. Overview
    • 9.5.48.2. Financial performance
    • 9.5.48.3. Product benchmarking
    • 9.5.48.4. Strategic initiatives
  • 9.5.49. Nuance Communications, Inc. (Microsoft)
    • 9.5.49.1. Overview
    • 9.5.49.2. Financial performance
    • 9.5.49.3. Product benchmarking
    • 9.5.49.4. Strategic initiatives
  • 9.5.50. Aiva, Inc.
    • 9.5.50.1. Overview
    • 9.5.50.2. Financial performance
    • 9.5.50.3. Product benchmarking
    • 9.5.50.4. Strategic initiatives